Bristol-Myers Squibb Company (BMY) — Technical state

As of 2026-10-06 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Pullback inside an uptrend stack

Trades -7.3% vs the 50-day and +0.7% vs the 200-day average, 13.2% below the 52-week high and +43.3% off the 52-week low. Computed from daily closes.

The moving-average stack

vs 20-day-4.2%
vs 50-day-7.3%
vs 200-day+0.7%
52-week band13.2% off the high · +43.3% off the low
Streak1 consecutive up session
50-day crossprice crossed down through the 50-day 14 sessions ago
Stochastic%K 20.9 · %D 16.8 · bull cross

Continue: the BMY chart & overview · the signal board

FAQ · from the current data · as of 2026-10-06

Quick answers

What is the current Closelooknet signal on BMY?

Pullback inside an uptrend stack — Trades -7.3% vs the 50-day and +0.7% vs the 200-day average, 13.2% below the 52-week high and +43.3% off the 52-week low. Computed from daily closes. As of 2026-10-06; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BMY above its 50-day and 200-day moving averages?

As of 2026-10-06, Bristol-Myers Squibb Company trades -7.3% below its 50-day and +0.7% above its 200-day average, with the 20-day -4.2% away.

How far is BMY from its 52-week high?

13.2% below the 52-week high and 43.3% above the 52-week low, as of 2026-10-06.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.